Pierre Massion, M.D.

Dr. Pierre Massion has worked in the field of lung cancer biology, early detection and therapeutics since 1999. He oversees and fosters a rich environment to translate science from the program to trials in the cooperative groups. His laboratory is funded by the NCI and the Veterans Administration to investigate novel strategies for the early detection and molecular characterization of early lung cancer. He has over 170 publications in the areas of lung cancer development, role of oncogenes in the progression of lung tumor cells, and innovative strategies towards the development of molecular biomarkers for early detection of lung cancer and intermediate endpoint biomarkers of response to chemoprevention. In recognition of his work, he was elected a fellow of the American Association for the Advancement of Science. Dr. Massion has mentored over 21 postdoctoral fellows, 11 graduate students and 20 undergraduate students.   He is the principal investigator of 8 trials listed on clinicaltrials.gov